Breast Biopsy (Modified Radical Mastectomy) Histopathology in UAE | 550 AED | 2026 DHA Guidelines

تحليل خزعة الثدي (استئصال الثدي الجذري المعدل) في الإمارات | 550 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

دقة تشخيصية بنسبة 99.9% عبر مختبر حاصل على شهادة ISO وباستخدام بروتوكولات متقدمة للكشف عن مستقبلات الهرمونات والجينات. Our ISO 9001:2015 certified lab guarantees precision with board-certified surgical pathologists. Premium cold-chain logistics ensure your tissue specimen is securely transported from the surgical suite to our lab. Post-test clinical guidance via telephonic consultation is included, and we support direct insurance billing – verify your coverage through WhatsApp at +971 54 548 8731. All services adhere to Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (minors consent), and UAE PDPL data privacy regulations.

Overview

The Breast Biopsy (Modified Radical Mastectomy) Histopathology test analyzes tissue removed after a radical mastectomy to detect any residual or recurrent breast cancer. Using advanced histopathology with optional immunohistochemistry (ER/PR/HER2) and genetic profiling, this test provides a definitive diagnosis that guides your oncologist’s treatment plan.

Features	Our	Routine Histopathology Lab
Precision & Subspecialty	Fellowship-trained surgical pathologists with breast pathology expertise	General pathologist, may lack breast specialization
Methodology	Histopathology + full IHC panel (ER, PR, HER2) & optional genetic testing (BRCA1/2)	Basic H&E staining only
Turnaround Time	6 working days with digital report access	10–14 days, paper report

Physician Insight & Safety Protocol

“A breast biopsy after modified radical mastectomy is a key step in confirming whether cancer remains or has returned. Please always correlate these results with your clinical examination and imaging. I strongly recommend discussing the findings with your oncologist before making any treatment decisions.”

— Dr. PRABHAKAR REDDY, DHA License 61713011

Safety Notice:

Exclusion Criteria: Active infection at the surgical site, known severe bleeding disorders (INR >1.5, platelets <50,000/mcL), or pregnancy (for certain histochemical stains).
ER Red Flags: Seek immediate medical attention if you experience severe chest pain, sudden shortness of breath, heavy bleeding or pus discharge from the site, or fever above 38°C.

Do not discontinue any prescribed medication without consulting your doctor.

Patient FAQs & Clinical Guidance

Why do I need a breast biopsy after a modified radical mastectomy?

This biopsy identifies any residual or recurrent breast cancer in the chest wall, ensuring timely treatment and monitoring. It also checks hormone receptor and HER2 status to guide ongoing therapy.

لماذا أحتاج إلى خزعة الثدي بعد استئصال الثدي الجذري المعدل؟

تحدد هذه الخزعة أي خلايا سرطانية متبقية أو متكررة في جدار الصدر، مما يضمن العلاج والمراقبة في الوقت المناسب، بالإضافة إلى تحليل مستقبلات الهرمونات وHER2.

How is the biopsy sample collected?

Your surgeon collects a tissue sample from the mastectomy site and sends it for microscopic examination. The procedure is performed under sterile conditions, often during a follow‑up surgery or as a needle biopsy.

كيف يتم جمع العينة؟

يقوم الجراح بجمع عينة نسيجية من موقع الاستئصال وإرسالها للفحص المجهري في ظروف معقمة.

What do the biopsy results mean?

Results indicate presence of cancer cells, receptor status, and HER2 expression to guide personalized treatment. A negative result does not rule out recurrence; clinical follow‑up remains essential.

ماذا تعني نتائج الخزعة؟

تشير النتائج إلى وجود خلايا سرطانية، وحالة مستقبلات الهرمونات، وتعبير HER2 لتوجيه العلاج الشخصي؛ ولا تستبعد النتيجة السلبية تكرار المرض تماماً.

دعم ثنائي اللغة متاح